Search Results

Containing any of the words

Only of the type

Multi-Center Open Label Study to Evaluate the Safety, Tolerability and Efficacy of Tocilizumab in Patients With Active Rheumatoid Arthritis on Background Non-biologic DMARDs Who Have An Inadequate Response to Current Non-Biologic DMARD or Anti-TNF Therapy Drug Clinical Trial

A Randomized, Open-label Phase III Intergroup Study: Effect of Adding Bevacizumab to Cross Over Fluoropyrimidine Based Chemotherapy (CTx) in Patients With Metastatic Colorectal Cancer and Disease Progression Under First-line Standard CTx/Bevacizumab Combination Drug Clinical Trial

A Phase 3, Randomized, Double-Blind, Placebo-Controlled, Multinational Clinical Study to Evaluate the Efficacy and Safety of 2.0 mg/kg/Week and 2.0 mg/kg/Every Other Week BMN 110 in Patients With Mucopolysaccharidosis IVA (Morquio A Syndrome) Drug Clinical Trial

A Multicenter, Multinational, Extension Study to Evaluate the Long-Term Efficacy and Safety of BMN 110 in Patients With Mucopolysaccharidosis IVA (Morquio A Syndrome) Drug Clinical Trial

SFDA Organizes a Workshop on Licensing of Additives Organizations News

(WU2419) NCMDR Weakly Update Medical Report

Authorization to Open Overseas Manufacturer Account Form Forms

SFDA Discusses “Drug Safety & Tracking and Adoption of Two-Dimensional Coding”. News

SFDA "Exhibited its efforts in organizing the Saudi pharmaceutical market through (DUPHAT – Dubai International Pharmaceuticals and Technologies Conference and Exhibition) in Dubai News

C1 esterase inhibitor (Human) Risk Minimization Activity - New